AMR is a significant threat to public health.
The NHS Long Term Plan identifies antimicrobial resistance as one of five priorities requiring NHS action on prevention, and reiterates the UK’s 20-year vision for AMR which outlines the aim for a world in which antimicrobial resistance is effectively contained, controlled and mitigated.
Under the overall theme of “Antimicrobial resistance (AMR)”, Competition 25 Phase 1 invites early-stage innovations in the following four priority areas:
The NHS Long Term Plan identifies antimicrobial resistance as one of five priorities requiring NHS action on prevention, and reiterates the UK’s 20-year vision for AMR which outlines the aim for a world in which antimicrobial resistance is effectively contained, controlled and mitigated.
Under the overall theme of “Antimicrobial resistance (AMR)”, Competition 25 Phase 1 invites early-stage innovations in the following four priority areas:
- Point of care diagnostics, monitoring, and susceptibility testing
- Prescribing decision support and risk stratification
- Novel care delivery methods
- Infection prevention and control (IPC)
